Renaissance Technologies’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-60,800
| Closed | -$12K | – | 4309 |
|
|
2023
Q2 | $12K | Sell |
60,800
-8,581
| -12% | -$1.69K | ﹤0.01% | 3821 |
|
|
2023
Q1 | $24K | Sell |
69,381
-13,419
| -16% | -$4.64K | ﹤0.01% | 3801 |
|
|
2022
Q4 | $27K | Buy |
+82,800
| New | +$27K | ﹤0.01% | 3909 |
|
|
2022
Q3 | – | Sell |
-19,742
| Closed | -$9K | – | 4529 |
|
|
2022
Q2 | $9K | Buy |
+19,742
| New | +$9K | ﹤0.01% | 4162 |
|
|
2021
Q1 | – | Sell |
-67,564
| Closed | -$168K | – | 3828 |
|
|
2020
Q4 | $168K | Buy |
67,564
+31,664
| +88% | +$78.7K | ﹤0.01% | 3175 |
|
|
2020
Q3 | $88K | Sell |
35,900
-23,475
| -40% | -$57.5K | ﹤0.01% | 3228 |
|
|
2020
Q2 | $211K | Sell |
59,375
-45,325
| -43% | -$161K | ﹤0.01% | 3143 |
|
|
2020
Q1 | $245K | Buy |
104,700
+69,019
| +193% | +$162K | ﹤0.01% | 3042 |
|
|
2019
Q4 | $78K | Buy |
35,681
+16,291
| +84% | +$35.6K | ﹤0.01% | 3349 |
|
|
2019
Q3 | $35K | Buy |
19,390
+4,490
| +30% | +$8.11K | ﹤0.01% | 3353 |
|
|
2019
Q2 | $22K | Buy |
+14,900
| New | +$22K | ﹤0.01% | 3493 |
|
|
2017
Q3 | – | Sell |
-54,500
| Closed | -$240K | – | 3426 |
|
|
2017
Q2 | $240K | Buy |
+54,500
| New | +$240K | ﹤0.01% | 2958 |
|
|
2014
Q3 | – | Sell |
-28,000
| Closed | -$139K | – | 2999 |
|
|
2014
Q2 | $139K | Buy |
28,000
+1,494
| +6% | +$7.42K | ﹤0.01% | 2620 |
|
|
2014
Q1 | $145K | Sell |
26,506
-16,794
| -39% | -$91.9K | ﹤0.01% | 2664 |
|
|
2013
Q4 | $263K | Buy |
43,300
+7,800
| +22% | +$47.4K | ﹤0.01% | 2536 |
|
|
2013
Q3 | $235K | Buy |
+35,500
| New | +$235K | ﹤0.01% | 2529 |
|